Advanced Proteome Therapeutics, Boston, Assigned Patent for Targeted Delivery of Proteins for Cancer Treatment
Copyright © Targeted News Service, 2017
2017-01-21
Copyright © Targeted News Service, 2017
2017-01-21
ALEXANDRIA, Va., Jan. 21 -- Advanced Proteome Therapeutics, Boston, has been assigned a patent (9,545,449) developed by Alexander Krantz, Boston, for "site-specific labeling and targeted delivery of proteins for the treatment of cancer."
The patent application was filed on May 13, 2013 (14/400,190). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,545,449.PN . . .
The patent application was filed on May 13, 2013 (14/400,190). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,545,449.PN . . .